Indications Under Development
Innovation With Speed
Reistone Biopharma is focused on the research and development of innovative medicines through global collaborations with sense of urgency.
Patient Need Is Our Passion
Research & Development
At Reistone, we devise our clinical research and development strategy around three key pillars: science, patient and market. These key pillars serve as our guiding principles in medicine development.
2021-08-25 Reistone Announces Positive Topline Phase 2 Results for SHR0302, a Selective JAK1 Inhibitor, for Treatment of Patients with Alopecia Areata
2021-05-14 Reistone Announces First Patient Dosed in Phase III Global Study in Atopic Dermatitis
2021-02-04 Positive Phase 2 Results for Reistone’s JAK Inhibitor Demonstrate Significant Improvement in Patients with Moderate-to-Severe Ulcerative Colitis
Partnership is core to our business model. We are committed to partnering with R&D based global pharma and biotech companies to bring innovative medicines to patients.
People represent our key success pillar. We are keen to recruit new talent into Reistone where you can develop and achieve your career aspirations.
Room 203, 2F, Xiangke Road,
Zhangjiang Hi-Tech Park,
Room 110, 3F, Air China Century Building,
No.40 Xiaoyun Road,
Chaoyang District,Beijing, China,100027
1 Lincoln Street,